13F filer · CIK 1582844
ACUTA CAPITAL PARTNERS, LLC
REDWOOD CITY, CA · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$143.5M
+$2.9M vs prior
Positions
23
New / sold out
5 / 9
Added / reduced
9 / 6
Turnover
23.6%
buys $33.5M · sells $43.7M
Top-10 weight
73.7%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ARRIVENT BIOPHARMA INC | +218,694 | – | +$7.6M |
| New | 4D MOLECULAR THERAPEUTICS INC | +507,801 | – | +$6.8M |
| Added | WHITEHAWK THERAPEUTICS INC | +1,275,510 | +37.4% | +$5.8M |
| New | AVALYN PHARMA INC | +115,000 | – | +$3.8M |
| New | ARTIVA BIOTHERAPEUTICS INC | +260,416 | – | +$2.5M |
| Added | AVALO THERAPEUTICS INC | +125,500 | +206.4% | +$2.3M |
| Added | DESIGN THERAPEUTICS INC | +136,664 | +93.7% | +$2.0M |
| New | CONTINEUM THERAPEUTICS INC-A | +63,095 | – | +$1.0M |
| Added | TAYSHA GENE THERAPIES INC | +122,344 | +27.8% | +$833.2K |
| Added | MOONLAKE IMMUNOTHERAPEUTICS | +23,892 | +12.5% | +$465.2K |
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | TERNS PHARMACEUTICALS INC | -495,772 | -100.0% | $-26.1M |
| Sold out | OCULIS HOLDING AG | -98,339 | -100.0% | $-2.6M |
| Sold out | REVOLUTION MEDICINES INC | -26,069 | -100.0% | $-2.5M |
| Sold out | 4D MOLECULAR THERAPEUTICS INC | -242,255 | -100.0% | $-2.3M |
| Reduced | ERASCA INC | -89,376 | -25.2% | $-1.6M |
| Sold out | IDEAYA BIOSCIENCES INC | -48,234 | -100.0% | $-1.6M |
| Reduced | TANGO THERAPEUTICS INC | -50,882 | -11.5% | $-1.6M |
| Reduced | BRIGHT MINDS BIOSCIENCES INC | -19,251 | -17.2% | $-1.4M |
| Sold out | ENTRADA THERAPEUTICS INC | -89,358 | -100.0% | $-1.1M |
| Reduced | PRAXIS PRECISION MEDICINES I | -2,105 | -2.5% | $-704.7K |
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES ICOM NEW | 82,796 | $27.7M | 19.32% |
| 2 | WHITEHAWK THERAPEUTICS INCCOM | 4,685,912 | $21.5M | 14.96% |
| 3 | TANGO THERAPEUTICS INCCOM | 390,949 | $12.2M | 8.52% |
| 4 | SUTRO BIOPHARMA INCCOM | 270,251 | $9.0M | 6.25% |
| 5 | ARRIVENT BIOPHARMA INCCOM | 218,694 | $7.6M | 5.29% |
| 6 | 4D MOLECULAR THERAPEUTICS INCCOM | 507,801 | $6.8M | 4.71% |
| 7 | BRIGHT MINDS BIOSCIENCES INCCOM NEW | 92,745 | $6.5M | 4.54% |
| 8 | OCULAR THERAPEUTIX INCCOM | 532,481 | $5.2M | 3.64% |
| 9 | ERASCA INCCOM | 265,199 | $4.9M | 3.39% |
| 10 | SURROZEN INCCOM NEW | 173,395 | $4.5M | 3.14% |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.